Neonc Technologies Holdings, Inc. SEC filings NTHI

Neonc Technologies Holdings, Inc. has 208 filings in SEC EDGAR's recent list, going back to Jun 22, 2023. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Neonc Technologies Holdings, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Sep 10, 2026 —
424B5 Prospectus supplement Jun 23, 2026 —
S-3 Shelf registration Jun 15, 2026 —
424B5 Prospectus supplement Apr 16, 2026 —
S-3 Shelf registration Apr 10, 2026 —
424B5 Prospectus supplement Apr 10, 2026 —
S-3 Shelf registration Apr 2, 2026 —
424B5 Prospectus supplement Feb 12, 2026 —
S-1 Registration statement Feb 6, 2026 —
424B5 Prospectus supplement Dec 23, 2025 —
S-1 Registration statement Dec 15, 2025 —
424B4 Prospectus Nov 13, 2025 —
424B5 Prospectus supplement Jun 16, 2025 —
S-1 Registration statement Jun 6, 2025 —
424B5 Prospectus supplement May 6, 2025 —
S-1 Registration statement Apr 29, 2025 —
S-8 Employee stock plan registration Mar 25, 2025 —
424B4 Prospectus Mar 25, 2025 —
S-1/A Amended registration statement Feb 26, 2025 —
S-1/A Amended registration statement Jan 31, 2025 —
S-1 Registration statement Jan 3, 2025 —
FWP Free writing prospectus Mar 1, 2024 —
S-1/A Amended registration statement Mar 1, 2024 —
S-1/A Amended registration statement Feb 23, 2024 —
S-1/A Amended registration statement Feb 5, 2024 —
S-1/A Amended registration statement Jan 16, 2024 —
S-1 Registration statement Dec 18, 2023 —

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NTHI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Calabasas, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1979414

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.